BPC-157is the most famous peptide on the internet. Body Protective Compound 157 is a synthetic fragment derived from a protein found in human gastric juice, and it’s become the default answer to every “I tweaked my shoulder in the gym” question on Reddit. The case for it is real. The hype is bigger than the case.
What it is
BPC-157 is a 15-amino-acid peptide. It promotes angiogenesis (new blood vessel formation), modulates the nitric oxide pathway, and accelerates healing of soft tissue: tendons, ligaments, muscle, gut lining. The animal data is extensive, consistent, and impressive. The human data is much thinner.
What the research actually shows
About 99% of the scientific evidence comes from animal models — predominantly rats. In those models, BPC-157 accelerates healing of transected Achilles tendons, reverses NSAID-induced gut damage, shortens recovery from muscle crush injuries, and upregulates growth hormone receptor expression in tendon fibroblasts (which is why it stacks with exogenous GH for tendon repair). The mechanism story is plausible and the effects are large.
In humans, the evidence is thin. One human clinical trial existed — run by Pharmacotherapy in 2015 — and it was cancelled before results were published. The best evidence we have is a 2021 retrospective study by Lee and Blake Padgett: intraarticular BPC-157 injections for various knee pain conditions, 16 patients, no control group, 87.5% reported improvement at 3–6 month follow-up. Encouraging, not conclusive. There is no FDA-approved indication. There is no large randomized controlled trial.
That doesn’t mean it doesn’t work in humans. It means we’re extrapolating from rat tendons to your shoulder, and that extrapolation is the asterisk.
How people dose it
From the field manual: 10 mg vial reconstituted with 2 mL BAC water yields 5 mg/mL. Common per-injection amounts, given twice daily (morning and evening) due to the short half-life:
- Low: 200 mcg per injection (4 units on a U-100 syringe)
- Medium: 500 mcg per injection (10 units)
- High: 500–1000 mcg per injection (10–20 units)
Inject subcutaneously, intramuscularly, or intraarticularly — as close to the injury site as possible. For an Achilles issue, that means the calf or ankle area, not abdominal fat.
What it stacks well with
TB-500 is the canonical pairing — different mechanism, complementary effect on tissue repair. KPV adds an anti-inflammatory layer. GHK-Cu adds collagen synthesis and skin quality. These four together make up the KLOW blend.
The honest caveats
- BPC-157 will not cause cancer. It can accelerate the growth of existing tumors. If you have any cancer history, this is a real concern, not a fig leaf.
- Not WADA-legal. If you compete in a tested sport, this is disqualifying.
- Not detected on standard workplace or military drug screens.
- Most users tolerate it well. Rare side effect: temporary blunted mood.
- The oral form exists and is bioavailable — it works for gut-targeted use because BPC-157 is a partial sequence of a compound found in the intestinal tract. For systemic or musculoskeletal use, injectable is the right route.
The bottom line
BPC-157 is the most evidence-rich underground peptide for soft-tissue healing, with the loudest evangelism and the largest gap between rat data and human data. If you have a stubborn injury that hasn’t responded to rest, stretching, and PT, it’s a defensible thing to try. If you expect it to fix something a doctor couldn’t fix, you’re asking for too much.
For the math, use the BPC-157 reconstitution calculator. For dosing, refer to the free Peptide Guide — it has the full BPC-157 protocol plus the rest of the recovery stack.